Indiana University scientists with expertise in optometry and artificial intelligence are among the first three groups of researchers to receive support from a new program from the National Institutes of Health supporting the emerging field of “oculomics,” which uses the eye as a lens on diseases that affect the whole body.
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here